{{Rsnum
|rsid=487591
|Gene=ENAH
|Chromosome=1
|position=225569049
|Orientation=minus
|GMAF=0.2718
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ENAH
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 6.4 | 45.5 | 48.2
| HCB | 8.3 | 32.6 | 59.1
| JPT | 11.6 | 39.3 | 49.1
| YRI | 2.8 | 20.1 | 77.1
| ASW | 1.8 | 29.8 | 68.4
| CHB | 8.3 | 32.6 | 59.1
| CHD | 11.3 | 44.3 | 44.3
| GIH | 32.7 | 48.5 | 18.8
| LWK | 3.8 | 34.9 | 61.3
| MEX | 10.5 | 47.4 | 42.1
| MKK | 4.0 | 23.8 | 72.2
| TSI | 8.9 | 45.5 | 45.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=19641378
|Title=The enabled homolog gene polymorphisms are associated with susceptibility and progression of childhood IgA nephropathy
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}